H.Res. 1125 · 116th Congress

Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.

Stage
In committee
Sponsor
Eliot Engel
Introduced
2020-09-18
Latest action
2020-09-18 · Introduced in House

Action history

  1. 2020-09-18Introduced in House
  2. 2020-09-18Referred to the House Committee on Energy and Commerce.